Skip to main content
TipRanks
Go Ultimate75% OFF

Lyell Immunopharma (LYEL) Drug Pipeline

163 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Lisocabtagene Maraleucel, Rondecabtagene Autoleucel, Axicabtagene CiloleucelDiffuse Large B Cell Lymphoma (Dlbcl), Lymphoma, B-Cell, Large B-Cell Lymphoma, Non-Hodgkin Lymphoma Refractory/ Relapsed, Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma RelapsedPhase IIIRecruitingA Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapySep 16, 2025
Impt-514Lupus Nephritis, Systemic Lupus Erythematosusphase1AndPhase2WithdrawnA Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)Nov 22, 2023―
Cyclophosphamide, Fludarabine, Lyl314Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphomaphase1AndPhase2RecruitingStudy of LYL314 in Aggressive Large B-Cell LymphomaMar 24, 2023
Lyl845Colorectal Cancer, Non-small Cell Lung Cancer, MelanomaPhase ITerminatedA Study to Investigate LYL845 in Adults With Solid TumorsOct 06, 2022―
Gcc19cartColorectal CancerPhase IRecruitingGCC19CART for Patients With Metastatic Colorectal CancerMar 23, 2022―
Lyl797Fallopian Tube Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Primary Peritoneal Carcinoma, Ovarian Cancer, Advanced Breast Cancer, Non Small Cell Lung Cancer, Nsclc Stage Iv, Non Small Cell Lung Cancer Metastatic, Triple Negative Breast Cancer, Nsclc, Ovarian Epithelial Cancer, Relapsed Cancer, Recurrent Breast Cancer, Tnbc - Triple-Negative Breast Cancer, Non-Small Cell Carcinoma Of Lung, Tnm Stage 4, Advanced Lung Carcinoma, Nsclc, Recurrent, Relapse/Recurrence, Recurrent Nsclc, Platinum-Resistant Ovarian Cancer, Endometrioid Tumor, High Grade Serous CarcinomaPhase ITerminatedA Study to Investigate LYL797 in Adults With Solid TumorsFeb 18, 2022―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Lyell Immunopharma, Inc. (LYEL) have in its pipeline
Lyell Immunopharma LYEL is currently developing the following drugs: Lisocabtagene Maraleucel, Rondecabtagene Autoleucel, Axicabtagene Ciloleucel, Impt-514, Cyclophosphamide, Fludarabine, Lyl314, Lyl845, Gcc19cart, Lyl797. These drug candidates are in various stages of clinical development as the company works toward FDA approval.